Doctor Leon Dinshaw
The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program
Event: ESC Congress 2021 - The Digital Experience
Topic: Anticoagulants
Session: Pharmacology and pharmacotherapy e-posters
Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program
Event: EHRA 2021
Topic: Oral Anticoagulation
Session: Prevention of stroke in atrial fibrillation
Long-term outcome of non-pharmacologial treatment of atrial fibrillation in hypertrophic cardiomyopathy: a large single-centre experience
Event: ESC Congress 2019
Topic: Rhythm Control, Hybrid Therapy
Session: Epidemiology of atrial fibrillation
Long-term outcome of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
Event: EHRA 2018
Topic: Rhythm Control, Hybrid Therapy
Session: Atrial fibrillation ablation - Mechanisms and outcomes
Elevated risk of ventricular tachyarrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy and a prolonged T-peak to T-end interval
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: ECG and arrhythmia analysis
Session: ECG and eCardiology
ESC 365 is supported by
